These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries. Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478 [TBL] [Abstract][Full Text] [Related]
3. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women. Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392 [TBL] [Abstract][Full Text] [Related]
4. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse. Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768 [TBL] [Abstract][Full Text] [Related]
5. Impact of convenience void in a bladder diary with urinary perception grade to assess overactive bladder symptoms: a community-based study. Honjo H; Kawauchi A; Nakao M; Ukimura O; Kitakoji H; Miki T Neurourol Urodyn; 2010 Sep; 29(7):1286-9. PubMed ID: 20878998 [TBL] [Abstract][Full Text] [Related]
6. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541 [TBL] [Abstract][Full Text] [Related]
8. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297 [TBL] [Abstract][Full Text] [Related]
9. Validation of the overactive bladder symptom score. Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C J Urol; 2007 Aug; 178(2):543-7; discussion 547. PubMed ID: 17570417 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761 [TBL] [Abstract][Full Text] [Related]
11. The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. Zinner N; Harnett M; Sabounjian L; Sandage B; Dmochowski R; Staskin D J Urol; 2005 May; 173(5):1639-43. PubMed ID: 15821526 [TBL] [Abstract][Full Text] [Related]
12. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis. Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD; J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910 [TBL] [Abstract][Full Text] [Related]
13. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103 [TBL] [Abstract][Full Text] [Related]
14. Urgency assessment in the evaluation of overactive bladder (OAB). Starkman JS; Dmochowski RR Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973 [TBL] [Abstract][Full Text] [Related]
15. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome. Chung SD; Liao CH; Chen YC; Kuo HC Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153 [TBL] [Abstract][Full Text] [Related]
16. Degree of urge, perception of bladder fullness and bladder volume--how are they related? Heeringa R; van Koeveringe GA; Winkens B; van Kerrebroeck PE; de Wachter SG J Urol; 2011 Oct; 186(4):1352-7. PubMed ID: 21855937 [TBL] [Abstract][Full Text] [Related]
17. Relationship between voided volume and the urge to void among patients with lower urinary tract symptoms. Blaivas JG; Tsui JF; Amirian M; Ranasinghe B; Weiss JP; Haukka J; Tikkinen KA Scand J Urol; 2014 Dec; 48(6):554-8. PubMed ID: 25029069 [TBL] [Abstract][Full Text] [Related]
18. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704 [TBL] [Abstract][Full Text] [Related]
19. Women overestimate daytime urinary frequency: the importance of the bladder diary. Stav K; Dwyer PL; Rosamilia A J Urol; 2009 May; 181(5):2176-80. PubMed ID: 19296975 [TBL] [Abstract][Full Text] [Related]
20. Which method is the most reliable in determination of bladder capacity in children with idiopathic overactive bladder? A comparison of maximum voided volume, uroflowmetry and maximum cystometric capacity. Uluocak N; Oktar T; Ander H; Ziylan O; Acar O; Rodoplu H; Erkormaz U J Pediatr Urol; 2009 Dec; 5(6):480-4. PubMed ID: 19342301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]